Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Europe Animal Health Market Size, Share and Trends Report, 2026-2033 | Market to Reach USD 39.9 Billion as Vaccines, Diagnostics and Pet Care Drive 10.6% CAGR

globenewswire.com

Europe Animal Health Market Size, Share and Trends Report, 2026-2033 | Market to Reach USD 39.9 Billion as Vaccines, Diagnostics and Pet Care Drive 10.6% CAGR Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Europe Animal Health Market Size, Share & Trends Analysis Report by Product, Animal Type, Distribution Channel, End-Use, Country, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The Europe animal health market was valued at an estimated USD 18.0 billion in 2025 and is projected to reach USD 39.9 billion by 2033, expanding at a CAGR of 10.6% from 2026 to 2033. Market growth is being driven by the increasing prevalence of zoonotic and infectious diseases, rising companion animal ownership, pet humanization, advances in veterinary pharmaceuticals and biologics, and stronger regulatory and food safety requirements.

Disease outbreaks across Europe are increasing demand for vaccines, diagnostics, preventive treatments, veterinary pharmaceuticals, and surveillance infrastructure. According to the French Agricultural Research Centre for International Development CIRAD, France experienced outbreaks of bluetongue virus (BTV) and epizootic hemorrhagic disease (EHD) in 2023, followed by the spread of a new BTV strain across Europe in 2024. These developments have encouraged governments, veterinary organizations, and animal health companies to strengthen biosecurity, herd protection, disease monitoring, and R&D programs.

Lumpy skin disease (LSD) has also intensified regional disease control efforts. Spain confirmed its 18th outbreak in Girona on 07 January 2026, while France reported a new case in Pamiers, Ariege, on 02 January 2026, resulting in the culling of 113 susceptible animals. In contrast, Sardinia, Italy, eliminated LSD as of 07 January 2026 after implementing a mandatory vaccination campaign covering approximately 300,000 cattle. These varied outcomes highlight the continuing importance of coordinated vaccination programs, veterinary interventions, and early disease detection across Europe.

The expanding companion animal population represents another major Europe animal health market growth driver. Pet owners are allocating more spending to premium nutrition, preventive care, diagnostic testing, medications, parasiticides, and wellness products. Animal Health Europe reported regional expenditure of EUR 28 billion on pet food, EUR 25 billion on pet-related goods and services, and EUR 4 billion on animal medications. Pet insurance adoption in countries including the UK, Sweden, and Germany is also improving access to veterinary treatment and supporting growth in the companion animal health sector.

Innovation in veterinary pharmaceuticals, vaccines, and biologics continues to improve disease prevention and treatment for livestock and companion animals. Key developments include next-generation vaccines, long-acting injectable products, and monoclonal antibodies. Animal Health Europe reported that the animal medicines industry invested more than USD 649 million in R&D during 2024. In the same year, the European Medicines Agency authorized 25 new animal health products for veterinary use. Continued product development is expected to improve treatment efficacy, support preventive healthcare adoption, and strengthen the region's animal health innovation pipeline.

Europe Animal Health Market Report Segmentation

The report provides regional and country-level revenue forecasts and analyzes industry trends across the Europe animal health market from 2021 to 2033. The study is segmented by product, animal type, distribution channel, end-use, and country.

Product Outlook (Revenue, USD Million, 2021-2033)

Animal Type Outlook (Revenue, USD Million, 2021-2033)

Distribution Channel Outlook (Revenue, USD Million, 2021-2033)

End-use Outlook (Revenue, USD Million, 2021-2033)

Country Outlook (Revenue, USD Million, 2021-2033)

Report Benefits

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased Database

1.3.2. Internal Database

1.3.3. Secondary Sources

1.3.4. Primary Research

1.4. Information/Data Analysis

1.5. Market Formulation & Visualization

1.6. Data Validation & Publishing

1.7. Model Details

1.7.1. Model 1 Analysis

1.7.2. Model 2 Analysis

1.7.3. Model 3 Analysis

1.7.4. Global Market: CAGR Calculation

1.8. List of Secondary Sources

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Europe Animal Health Market Variables, Trends, & Scope

3.1. Market Dynamics

3.1.1. Market Drivers Analysis

3.1.2. Market Restraints Analysis

3.1.3. Market Opportunity Analysis

3.1.4. Market Challenge Analysis

3.2. Animal Health Market Analysis Tools

3.2.1. Porter's Five Forces Analysis

3.2.2. PESTEL Analysis, by SWOT

3.3. Estimated Animal Population, by Key Species & Key Countries, 2025

3.4. Pricing Analysis

3.5. Pet Owner Demographics in Key Countries

Chapter 4. Europe Animal Health Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Europe Animal Health Market: Product Movement Analysis, 2025 & 2033 (USD Billion)

4.3. Biologics

4.3.1. Biologics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.3.2. Vaccines

4.3.3. Other Biologics

4.4. Pharmaceuticals

4.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.4.2. Parasiticides

4.4.3. Anti-infectives

4.4.4. Anti-inflammatory

4.4.5. Analgesics

4.4.6. Others

4.5. Diagnostics

4.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.5.2. Consumables, reagents and kits

4.5.3. Instruments and devices

4.6. Equipment & Disposables

4.6.1. Equipment & Disposables Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.6.2. Critical Care Consumables

4.6.3. Anesthesia Equipment

4.6.4. Fluid Management Equipment

4.6.5. Temperature Management Equipment

4.6.6. Rescue & Resuscitation Equipment

4.6.7. Research Equipment

4.6.8. Patient Monitoring Equipment

4.7. Medicinal Feed Additives

4.7.1. Medicinal Feed Additives Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.8. Other Products

4.8.1. Other Products Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.8.2. Veterinary Telehealth

4.8.3. Veterinary Software

4.8.4. Livestock Monitoring

Chapter 5. Europe Animal Health Market: Distribution Channel Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Europe Animal Health Market: Distribution Channel Movement Analysis, 2025 & 2033 (USD Billion)

5.3. Retail

5.3.1. Retail Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

5.4. E-Commerce

5.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

5.5. Hospital/ Clinic Pharmacy

5.5.1. Hospital/ Clinic Pharmacy Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 6. Animal Health Market: Animal Type Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Animal Health Market: Animal Type Movement Analysis, 2025 & 2033 (USD Billion)

6.3. Production Animals

6.3.1. Production Animals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

6.3.2. Poultry

6.3.3. Swine

6.3.4. Cattle

6.3.5. Sheep & Goats

6.3.6. Fish

6.4. Companion Animals

6.4.1. Companion Animals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

6.4.2. Dogs

6.4.3. Cats

6.4.4. Horses

6.4.5. Others

Chapter 7. Europe Animal Health Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard

7.2. Europe Animal Health Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)

7.3. Veterinary Reference Laboratories

7.3.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

7.4. Point-of-care Testing/In-house Testing

7.4.1. Point-of-care Testing/In-house Testing Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

7.5. Veterinary Hospitals & Clinics

7.5.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

7.6. Others

7.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 8. Europe Animal Health Market: Regional Estimates & Trend Analysis

8.1. Europe Animal Health Market Share, by Region, 2025 & 2033 (USD Million)

8.2. Country Outlook

8.3. Europe

8.3.1. Europe Animal Health Market Estimates and Forecasts, 2021-2033 (USD Million)

8.3.2. UK

8.3.3. Germany

8.3.4. France

8.3.5. Italy

8.3.6. Spain

8.3.7. Russia

8.3.8. Netherlands

8.3.9. Switzerland

8.3.10. Sweden

8.3.11. Ireland

8.3.12. Poland

8.3.13. Denmark

8.3.14. Norway

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization

9.2. Company Market Position Analysis/ Heap Map Analysis

9.3. Company Profiles

9.3.1. Zoetis

9.3.2. Ceva Sante Animale

9.3.3. MSD

9.3.4. Vetoquinol S.A.

9.3.5. Boehringer Ingelheim Gmbh

9.3.6. Elanco

9.3.7. Virbac

9.3.8. B. Braun Vet Care

9.3.9. Dechra Pharmaceuticals Plc

9.3.10. Idexx Laboratories, Inc.

9.3.11. Bimeda Inc.

9.4. Strategy Mapping

9.4.1. Mergers & Acquisitions

9.4.2. Partnerships & Collaborations

9.4.3. Others

9.5. List of Other Key Manufacturers

9.6. List of Distributors by Region

List of Tables [174]

List of Figures [85]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/mvg6a4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.